Rami Rhaiem
Overview
Explore the profile of Rami Rhaiem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Ponthaud C, Nassar A, Dokmak S, Bertrand T, De Martino J, Pastier C, et al.
Ann Surg
. 2025 Feb;
PMID: 40018739
Objectives: To identify risk factors for conversion, develop a predictive Conversion Risk Score (CRS), and assess the association between conversion and severe postoperative complications. Background: Conversion occurs in 15-30% of...
2.
Addeo P, Muzzolini M, Laurent C, Heyd B, Sauvanet A, Garnier J, et al.
Ann Surg Oncol
. 2025 Feb;
32(4):2861-2863.
PMID: 39893336
No abstract available.
3.
Addeo P, Muzzolini M, Laurent C, Heyd B, Sauvanet A, Garnier J, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2874-2875.
PMID: 39878841
No abstract available.
4.
Addeo P, Muzzolini M, Laurent C, Heyd B, Sauvanet A, Garnier J, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2809-2818.
PMID: 39777595
Background: The use of multiagent FOLFIRINOX chemotherapy for pancreatic adenocarcinoma in a neoadjuvant setting has been associated with an increased rate of complete pathological response (CPR) after surgery. This study...
5.
Karam E, Hollenbach M, Heise C, Ali E, Gulla A, Auriemma F, et al.
Endocr Relat Cancer
. 2025 Jan;
32(3.
PMID: 39745186
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor (CoGNET), previously called ampullary gangliocytic paragangliomas, is a rare entity, with only few reported cases in the literature. This is a multicentric retrospective cohort...
6.
Vigneron P, Franze M, Chalaye J, Tacher V, Sessa A, Luciani A, et al.
Hepatobiliary Surg Nutr
. 2024 Dec;
13(6):974-990.
PMID: 39669087
Background And Objective: Selective internal radiation therapy (SIRT) represents an endovascular treatment option for patients with hepatocellular carcinoma (HCC). Its use is widely recognized in the intermediate and advanced HCC,...
7.
Franze M, Vigneron P, Sessa A, Saitta C, Chalaye J, Tacher V, et al.
Ann Hepatol
. 2024 Aug;
30(1):101539.
PMID: 39179159
Selective internal radiation therapy (SIRT) has emerged as a viable endovascular treatment strategy for hepatocellular carcinoma (HCC). According to the Barcelona Clinic Liver Cancer (BCLC) classification, SIRT is currently recommended...
8.
Brugel M, Callon S, Carlier C, Amroun K, Botsen D, Kianmanesh R, et al.
United European Gastroenterol J
. 2024 Aug;
12(7):951-959.
PMID: 39118264
Background: Knowledge about environmental pancreatic adenocarcinoma (PA) risk factors, including pesticide exposure, remains limited. Organochlorine (OC) accumulates in adipose tissue and can help reflect long-term exposure. Patients And Methods: Age...
9.
Giannone F, Felli E, Cipriani F, Branciforte B, Rhaiem R, Al Taweel B, et al.
HPB (Oxford)
. 2024 Mar;
26(6):840-850.
PMID: 38553263
Background: Hepatocellular carcinoma (HCC) have a dismal prognosis and any effective neoadjuvant treatment has been validated to date. We aimed to investigate the role of neoadjuvant transarterial chemoembolization (TACE) in...
10.
Rhaiem R, Durame A, Primavesi F, Dorcaratto D, Syn N, de la Hoz Rodriguez A, et al.
Surgery
. 2024 Mar;
176(1):124-133.
PMID: 38519408
Background: KRAS mutation is a negative prognostic factor for colorectal liver metastases. Several studies have investigated the resection margins according to KRAS status, with conflicting results. The aim of the...